Bioxytran (BIXT) Short Interest Ratio & Short Volume

Short interest is the volume of Bioxytran shares that have been sold short but have not yet been covered or closed out. As of October 15th, investors have sold 100 shares of BIXT short. Learn More on Bioxytran's current short interest.

Bioxytran saw a drop in short interest in October. As of October 15th, there was short interest totaling 100 shares, a drop of 99.1% from the previous total of 11,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Bioxytran: Clene Inc. (2.91%), ImmuCell Co. (0.09%), Estrella Immunopharma, Inc. (0.06%), Passage Bio, Inc. (3.21%), Acasti Pharma Inc. (2.47%), ProMIS Neurosciences, Inc. (1.16%), Janone Inc. (1.13%), Lantern Pharma Inc. (2.06%), HCW Biologics Inc. (0.04%), BioVie Inc. (35.04%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.14 billion), AppLovin Co. ($3.15 billion), Paychex, Inc. ($2.69 billion), Nu Holdings Ltd. ($2.48 billion), Cencora, Inc. ($2.24 billion), International Paper ($2.04 billion), Tractor Supply ($1.96 billion), Coinbase Global, Inc. ($1.93 billion), Moderna, Inc. ($1.91 billion), and SoFi Technologies, Inc. ($1.84 billion). View all of the most shorted stocks.

Short selling BIXT is an investing strategy that aims to generate trading profit from Bioxytran as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Bioxytran occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of BIXT, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BIXT, twice per month. The most recent reporting period available is October, 15 2024.